(Q31943869)

5 July 2017

title

Treatment of oral leukoplakia by topical application of 5-aminolevulinic acid (English)

1 reference

5 July 2017

1 reference

oral mucosa leukoplakia

1 reference

A Kübler

1

1 reference

5 July 2017

T Haase

2

1 reference

5 July 2017

M Rheinwald

3

1 reference

5 July 2017

T Barth

4

1 reference

5 July 2017

J Mühling

5

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

International Journal of Oral and Maxillofacial Surgery

5 July 2017

published in

1 reference

5 July 2017

volume

27

1 reference

5 July 2017

issue

6

1 reference

5 July 2017

page(s)

466-469

1 reference

Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2898%2980040-4

7 January 2021

The pH dependency of protoporphyrin IX formation in cells incubated with 5-aminolevulinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2898%2980040-4

7 January 2021

Primary clinical response and long-term follow-up of solar keratoses treated with topically applied 5-aminolevulinic acid and irradiation by different wave bands of light

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2898%2980040-4

7 January 2021

Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2898%2980040-4

7 January 2021

How does photodynamic therapy work?

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2898%2980040-4

7 January 2021

Tumour photosensitizers: approaches to enhance the selectivity and efficiency of photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2898%2980040-4

7 January 2021

Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2898%2980040-4

7 January 2021

Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2898%2980040-4

7 January 2021

Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2898%2980040-4

7 January 2021

[Photodynamic diagnosis of neoplasms of the mouth cavity after local administration of 5-aminolevulinic acid]

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2898%2980040-4

7 January 2021

Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2898%2980040-4

7 January 2021

Photofrin-mediated photodynamic therapy of chemically-induced premalignant lesions and squamous cell carcinoma of the palatal mucosa in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2898%2980040-4

7 January 2021

Photophysical and photobiological processes in the photodynamic therapy of tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2898%2980040-4

7 January 2021

Oral leukoplakia: a clinicopathological review

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2898%2980040-4

7 January 2021

Plasma levels of protoporphyrin IX in humans after oral administration of 5-aminolevulinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2898%2980040-4

7 January 2021

On-line fluorescence of human tissues after oral administration of 5-aminolevulinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2898%2980040-4

7 January 2021

10.1016/S0901-5027(98)80040-4

Identifiers

DOI

1 reference

5 July 2017

1 reference